SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NPSP NPS Pharmaceutical
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (199)3/9/2004 9:46:23 PM
From: mopgcw   of 363
 
Again, I hear, though I can't confirm, that Amgen got an approvable letter for predialysis population but will have to conduct trials.

Piper Jaffray reports that they did get predialysis for both pimary and secondary HPT, there are ongoing studies and they expect approval in lat '04 early '05.

they are forecasting '04 sales of $14mm and '05 of $63mm also due to reimbursement impact.

They also expect the preos data at the end of March.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News